Replies to post #38627 on ProText Mobility Inc (TXTM)

[highlandernew]

"...The trial, SPONSORED BY ProText Mobility, Inc., will be conducted by the Centre International de Developpment Pharmaceutique (CIDP) in the country of Mauritius. Mauritius was selected as the site for the human clinical trial because an estimated 25% of the population suffers from Type II Diabetes..."

OK, so we (shareholders of TXTM) are the GUINEA PIGS of PLPL?

What does TXTM get back in REVENUE (i.e. shareholders value) for this?

What are your thoughts about this?